Log in

Relevant bibliographies by topics / MHC class I - antigens

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'MHC class I - antigens'

Author: Grafiati

Published: 4 June 2021

Last updated: 3 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'MHC class I - antigens.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "MHC class I - antigens"

1

Davies, T. F., S. H. Roman, W. A. Mackenzie, N. Goldsmith, S. M. Dower, and L. A. Piccinini. "Thyroid cell MHC class II antigens:." Acta Endocrinologica 116, no. 1_Suppl (1987): S13—S20. http://dx.doi.org/10.1530/acta.0.114s013.

Full text

Abstract:

Abstract. An association exists between certain MHC polymorphisms and autoimmune thyroid disease in animals and humans. The observation of MHC class II antigen expression by the thyroid suggests that such associations may have mechanistic explanations at the level of the thyroid cell. Such class II antigen expression, rather than being a constitutive property of thyroid epithelium, appears to be primarily mediated by lymphokine secretion from intrathyroidal T lymphocytes and a variety of agents, for example TSH and TSH receptor antibodies, may amplify such lymphokine action. Thyroid cell class

APA, Harvard, Vancouver, ISO, and other styles

2

Donaldson, W. L., C. H. Zhang, J. G. Oriol, and D. F. Antczak. "Invasive equine trophoblast expresses conventional class I major histocompatibility complex antigens." Development 110, no. 1 (1990): 63–71. http://dx.doi.org/10.1242/dev.110.1.63.

Full text

Abstract:

Monoclonal antibodies and alloantisera were used in an indirect immunohistochemical assay to determine the expression of class I and class II Major Histocompatibility Complex (MHC) antigens by equine placental cells and the endometrial tissues at the fetal-maternal interface. MHC class I antigens were expressed at high density on the surface of the trophoblast cells of the chorionic girdle at days 32–36, just prior to their invasion of the endometrium. The mature gonadotrophin-secreting cells of the endometrial cups, which are derived from the chorionic girdle cells, had greatly reduced levels

APA, Harvard, Vancouver, ISO, and other styles

3

Siegrist, C. A., E. Martinez-Soria, I. Kern, and B. Mach. "A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gamma." Journal of Experimental Medicine 182, no. 6 (1995): 1793–99. http://dx.doi.org/10.1084/jem.182.6.1793.

Full text

Abstract:

Presentation of exogenous protein antigens to T lymphocytes is based on the intersection of two complex pathways: (a) synthesis, assembly, and transport of major histocompatibility complex (MHC) class II-invariant chain complexes from the endoplasmic reticulum to a specialized endosomal compartment, and (b) endocytosis, denaturation, and proteolysis of antigens followed by loading of antigenic peptides onto newly synthesized MHC class II molecules. It is believed that expression of MHC class II heterodimers, invariant chain and human leukocyte antigen-DM is both necessary and sufficient to rec

APA, Harvard, Vancouver, ISO, and other styles

4

Lu, L., LM Pelus, HE Broxmeyer, et al. "Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8- positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E." Blood 68, no. 1 (1986): 126–33. http://dx.doi.org/10.1182/blood.v68.1.126.126.

Full text

Abstract:

Abstract The relationship between major histocompatibility complex class II antigens (MHC class II, eg, HLA-DR, Ia), T lymphocytes, and the enhancement of erythroid colony formation from BFU-E by prostaglandin E was analyzed using normal bone marrow cells. In primary methylcellulose culture, the addition of prostaglandin E1 (PGE1) to unseparated buffy coat, low-density, or nonadherent low-density (NAL) marrow cells resulted in an enhancement of the total number of erythroid (BFU-E) colonies observed. Treatment of bone marrow cells with a monoclonal antihuman MHC class II antibody plus compleme

APA, Harvard, Vancouver, ISO, and other styles

5

Lu, L., LM Pelus, HE Broxmeyer, et al. "Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8- positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E." Blood 68, no. 1 (1986): 126–33. http://dx.doi.org/10.1182/blood.v68.1.126.bloodjournal681126.

Full text

Abstract:

The relationship between major histocompatibility complex class II antigens (MHC class II, eg, HLA-DR, Ia), T lymphocytes, and the enhancement of erythroid colony formation from BFU-E by prostaglandin E was analyzed using normal bone marrow cells. In primary methylcellulose culture, the addition of prostaglandin E1 (PGE1) to unseparated buffy coat, low-density, or nonadherent low-density (NAL) marrow cells resulted in an enhancement of the total number of erythroid (BFU-E) colonies observed. Treatment of bone marrow cells with a monoclonal antihuman MHC class II antibody plus complement (C') r

APA, Harvard, Vancouver, ISO, and other styles

6

Kao, K. J., and M. L. U. del Rosario. "Role of Class-II Major Histocompatibility Complex (MHC)-Antigen–Positive Donor Leukocytes in Transfusion-Induced Alloimmunization to Donor Class-I MHC Antigens." Blood 92, no. 2 (1998): 690–94. http://dx.doi.org/10.1182/blood.v92.2.690.

Full text

Abstract:

Abstract It has been shown that peripheral-blood mononuclear leukocytes (MNL) are responsible for transfusion-induced alloimmunization to donor major histocompatability complex (MHC) antigens. However, it is not known which subset of MNL is responsible for this immune response. Because elimination of class-II MHC antigen-positive passenger leukocytes effectively prolongs the survival of allografts, it has been hypothesized that class-II positive MNL are responsible for immunizing transfusion recipients to donor MHC antigens. To test this hypothesis, two different approaches were used. First, w

APA, Harvard, Vancouver, ISO, and other styles

7

Kao, K. J., and M. L. U. del Rosario. "Role of Class-II Major Histocompatibility Complex (MHC)-Antigen–Positive Donor Leukocytes in Transfusion-Induced Alloimmunization to Donor Class-I MHC Antigens." Blood 92, no. 2 (1998): 690–94. http://dx.doi.org/10.1182/blood.v92.2.690.414k12_690_694.

Full text

Abstract:

It has been shown that peripheral-blood mononuclear leukocytes (MNL) are responsible for transfusion-induced alloimmunization to donor major histocompatability complex (MHC) antigens. However, it is not known which subset of MNL is responsible for this immune response. Because elimination of class-II MHC antigen-positive passenger leukocytes effectively prolongs the survival of allografts, it has been hypothesized that class-II positive MNL are responsible for immunizing transfusion recipients to donor MHC antigens. To test this hypothesis, two different approaches were used. First, we compare

APA, Harvard, Vancouver, ISO, and other styles

8

Delamarre, Lélia, Hilda Holcombe, and Ira Mellman. "Presentation of Exogenous Antigens on Major Histocompatibility Complex (MHC) Class I and MHC Class II Molecules Is Differentially Regulated during Dendritic Cell Maturation." Journal of Experimental Medicine 198, no. 1 (2003): 111–22. http://dx.doi.org/10.1084/jem.20021542.

Full text

Abstract:

During maturation, dendritic cells (DCs) regulate their capacity to process and present major histocompatibility complex (MHC) II–restricted antigens. Here we show that presentation of exogenous antigens by MHC I is also subject to developmental control, but in a fashion strikingly distinct from MHC II. Immature mouse bone marrow–derived DCs internalize soluble ovalbumin and sequester the antigen intracellularly until they receive an appropriate signal that induces cross presentation. At that time, peptides are generated in a proteasome-dependent fashion and used to form peptide–MHC I complexe

APA, Harvard, Vancouver, ISO, and other styles

9

Lankar, Danielle, Volker Briken, Kristin Adler та ін. "Syk Tyrosine Kinase and B Cell Antigen Receptor (BCR) Immunoglobulin-α Subunit Determine BCR-mediated Major Histocompatibility Complex Class II–restricted Antigen Presentation". Journal of Experimental Medicine 188, № 5 (1998): 819–31. http://dx.doi.org/10.1084/jem.188.5.819.

Full text

Abstract:

Stimulation of CD4+ helper T lymphocytes by antigen-presenting cells requires the degradation of exogenous antigens into antigenic peptides which associate with major histocompatibility complex (MHC) class II molecules in endosomal or lysosomal compartments. B lymphocytes mediate efficient antigen presentation first by capturing soluble antigens through clonally distributed antigen receptors (BCRs), composed of membrane immunoglobulin (Ig) associated with Ig-α/Ig-β heterodimers which, second, target antigens to MHC class II–containing compartments. We report that antigen internalization and an

APA, Harvard, Vancouver, ISO, and other styles

10

Gelderblom, Hans, Hilmar Reupke, Thorsten Winkel, Rudolf Kunze, and Georg Pauli. "MHC-Antigens: Constituents of the Envelopes of Human and Simian Immunodeficiency." Zeitschrift für Naturforschung C 42, no. 11-12 (1987): 1328–34. http://dx.doi.org/10.1515/znc-1987-11-1230.

Full text

Abstract:

Immunoelectron microscopy was applied to study the antigenic make-up of human and simian immunodeficiency viruses (HIV, SIV) grown in cells expressing either MHC class I (Molt-3) or MHC class I and II (H9) antigens. A variety of antibodies directed against the surface glycopro tein gpl20 of HIV and against MHC class I and II antigens were employed. Consistent with earlier observations on the loss of HIV envelope components, gp120 was only weakly demonstra ble on the mature virion. MHC class I determinants were present regularly in small amounts on HIV and SIV. Class II antigens, e.g. HLA-DR

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "MHC class I - antigens"

1

Lill, Jennie Rebecca. "Characterisation of MHC class I tumour antigens." Thesis, Nottingham Trent University, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.366082.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Talken, Beth L. "Assembly of the Lw¹⁶ and Ld class I MHC molecules." free to MU campus, to others for purchase, 1996. http://wwwlib.umi.com/cr/mo/fullcit?p9720532.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Beers, Courtney. "The role of cysteine proteases in MHC class II antigen processing and presentation /." Thesis, Connect to this title online; UW restricted, 2004. http://hdl.handle.net/1773/8321.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Lenz, Laurel L. "Presentation of formylated bacterial peptides to cytotoxic T cells by an MHC class Ib molecule /." Thesis, Connect to this title online; UW restricted, 1998. http://hdl.handle.net/1773/8339.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Stones, Daniel Henry. "Immune presentation and recognition of class I MHC phosphopeptide antigens." Thesis, University of Birmingham, 2013. http://etheses.bham.ac.uk//id/eprint/4048/.

Full text

Abstract:

Alterations to metabolic pathways, in particular post-translational modification, are a recognised hallmark of diseases such as autoimmunity, inflammation and cancer, and potentially provide a source of altered self antigens that can stimulate immune responses. Most notably, phosphorylated peptides have emerged as a group of tumour associated antigens which can be presented by MHC molecules and recognised by T-cells, and therefore represent promising candidates for future cancer immunotherapy strategies. However, how antigen phosphorylation impacts upon antigen presentation and recognition rem

APA, Harvard, Vancouver, ISO, and other styles

6

Waldenström, Margareta. "Mapping of the specificity in MHC class I recognition by natural killer cells /." Stockholm : Karolinska Univ. Press, 2000. http://diss.kib.ki.se/2000/91-89428-03-x/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Spencer, S. C. "Biochemical and immunological studies of class 1 and class 2 MHC antigens in the rat." Thesis, University of Brighton, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.374875.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Parker, Kay Elizabeth. "Genetic and immunological studies on class I MHC antigens of the rat." Thesis, Open University, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.278511.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Barton, Gregory Methven. "Positive selection of CD4 T cells by specific peptide-MHC class II complexes /." Thesis, Connect to this title online; UW restricted, 2000. http://hdl.handle.net/1773/4994.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sundbäck, Jonas. "NK cell inhibitory receptor interactions with MHC class I molecules /." Stockholm, 2001. http://diss.kib.ki.se/2001/91-628-4819-4/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "MHC class I - antigens"

1

Aptsiauri, Natalia, Angel Miguel Garcia-Lora, and Teresa Cabrera. MHC Class I Antigens In Malignant Cells. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-6543-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Douglas, Michael Richard. Molecular aspects of class II MHC antigen presentation. University of Birmingham, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Noakes, Karen Louise. Exploiting the retrograde transport of disarmed toxins for the delivery of exogenous antigens into MHC class 1 presentation pathway. typescript, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Rust, Nigel Anthony. Analysis of the human MCH class II antigens by two dimensional gel electrophoresis. Oxford Polytechnic, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

1943-, Peña José, ed. MHC antigens and NK cells. R.G. Landes, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Harding, Clifford V. MHC molecules and antigen processing. R.G. Landes Co., 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Solheim, Bjarte G., Erna Møller, and Soldano Ferrone, eds. HLA Class II Antigens. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70367-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Blancher, Antoine, Jan Klein, and Wladyslaw Socha, eds. Molecular Biology and Evolution of Blood Group and MHC Antigens in Primates. Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-59086-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Garrido, Federico. MHC Class-I Loss and Cancer Immune Escape. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-17864-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sidhu, Nirmal K. Regional variation in expression of major histocompatibility class II antigens in enterocytes of postnatal and adult mice. National Library of Canada, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "MHC class I - antigens"

1

Broudy, V. C., and J. H. Fitchen. "Class II MHC Antigens and Hematopoiesis." In HLA Class II Antigens. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70367-6_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Torok-Storb, B., and F. W. Symington. "Class II MHC Antigens and Erythropoiesis." In HLA Class II Antigens. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70367-6_23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Aptsiauri, Natalia, Angel Miguel Garcia-Lora, and Teresa Cabrera. "Overview of MHC Class I Antigens." In MHC Class I Antigens In Malignant Cells. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-6543-0_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ostrand-Rosenberg, Suzanne, Geoffrey A. Cole, Gerald A. Cole, et al. "Role of MHC Class I Antigens in Tumor Rejection." In H-2 Antigens. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4757-0764-9_41.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Stastny, P., G. Nuñez, and C. Pettaway. "Class II MHC Antigens on Human Monocytes, Endothelial Cells, and Dendritic Cells." In HLA Class II Antigens. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70367-6_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Duquesnoy, R. J., and A. Zeevi. "Cellular Detection of Human Class II MHC Antigens by Alloreactive T Cell Clones." In HLA Class II Antigens. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70367-6_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Singh, P. B., R. E. Brown, and B. J. Roser. "Soluble Classical Class I MHC Antigens in Solution in the Body Fluids." In MHC + X. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-74026-8_33.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Wakeland, Edward K., Roy W. Tarnuzzer, Cheng-Chan Lu, et al. "The Evolution of MHC Class II Genes within the Genus Mus." In H-2 Antigens. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4757-0764-9_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Doherty, Peter C. "Historical Developments in Understanding the Function of Class I MHC Genes." In H-2 Antigens. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4757-0764-9_34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Bushkin, Yuri, Hidehiro Watanabe, and Sandra Demaria. "Extracellular Processing of MHC Class I Antigens." In Immunobiology of Organ Transplantation. Springer US, 2004. http://dx.doi.org/10.1007/978-1-4419-8999-4_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "MHC class I - antigens"

1

Kim, Yohan, Jonathan W. Yewdell, and Bjoern Peters. "Determining positional bias of MHC class I restricted T-cell epitopes in viral antigens." In the 2nd ACM Conference. ACM Press, 2011. http://dx.doi.org/10.1145/2147805.2147909.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Yarmarkovich, Mark, Moreno Di Marco, Olivia Padovan, et al. "Abstract 5824: MHC class I immunogenicity and novel tumor antigen discovery in neuroblastoma." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-5824.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Tamhane, Tripti, Sunil Kumar Saini, Raghavendra Anjanappa, et al. "Abstract B049: Empty MHC class I molecules for improved detection of antigen-specific T-cells." In Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-b049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Boucher, Tommy, Matthew Davis, Christine Palmer, et al. "Abstract 4445: MHC class II antigen identification for cancer immunotherapy by deep learning on tumor HLA peptides." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-4445.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Boucher, Tommy, Matthew Davis, Christine Palmer, et al. "Abstract 4445: MHC class II antigen identification for cancer immunotherapy by deep learning on tumor HLA peptides." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-4445.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

McKinnon, Alyson, Nathan Avaritt, Alan Tackett, and Brian Koss. "Abstract 1892: Proteomic interrogation of the metabolic control of MHC class I antigen presentation in metastatic melanoma." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1892.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Pires, Pedro Ratto Lisboa, Pedro L. P. Xavier, and Heidge Fukumasu. "Abstract B180: Effects of EMT process under MHC class I and TAP1 gene expression related to antigen presentation." In Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-b180.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Wang, X., T. Meul, I. E. Kammerl, et al. "Mitochondrial DNA stress activates MHC class I antigen presentation and CD8+ T-cell immunity: implications for pulmonary fibrosis." In ERS Lung Science Conference 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/23120541.lsc-2021.105.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Fourcade, Julien, Zhaojun Sun, Ornella Pagliano, et al. "Abstract 4576: Immunization with CPG in combination with MHC class I and class II peptides stimulates rapid and strong tumor antigen-specific CTL responses in melanoma patients." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-4576.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Jiang, Xianpeng, Jeff Phillips, Jonathan F. Head, Brian Barnett, and Robert L. Elliott. "Abstract 5327: Upregulation of the expression of nonclassical MHC class I HLA-G antigen in human breast cancer cell lines and tissue." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-5327.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "MHC class I - antigens"

1

Worsham, Maria J., Usha Raju, and Judith Abrams. Population Based Assessment of MHC Class I Antigens Down Regulation as Markers of Increased Risk for Development and Progression of Breast Cancer From Benign Breast Lesions. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada413876.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Worsham, Maria J. Population Based Assessment of MHC Class I Antigens Down Regulation as Markers of Increased Risk for Development and Progression of Breast Cancer From Benign Breast Lesions. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada425768.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Worsham, Maria J. Population Based Assessment of MHC Class I Antigens Down Regulation as Markers of Increased Risk for Development and Progression of Breast Cancer from Benign Breast Lesions. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada469963.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bennett, Michael. Molecular Basis of Natural Killer Cell Tumor Target Recognition: The NKr/MHC Class I Complex. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada398189.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Deist, Melissa S., Rodrigo A. Gallardo, David A. Bunn, et al. More MHC-like Class I Y mRNA Detected in Relatively Resistant Fayoumis than Susceptible Leghorns. Iowa State University, 2018. http://dx.doi.org/10.31274/ans_air-180814-315.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Martin, Brian K., and Jenny Ting. The Effect of MHC Class II Transactivator on the Growth and Metastasis of Breast Tumors. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada374042.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Hasemann, Charles A. Molecular Basis of Natural Killer Cell Tumor Target Recognition: The NKr/MHC Class I Complex. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada391281.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Martin, Brian. The Effect of MHC Class II Transactivator (CIITA) on the Growth and Metastasis of Breast Tumors. Defense Technical Information Center, 1998. http://dx.doi.org/10.21236/ada353890.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Martin, Brian K., and Jenny Ting. The Effects of the MHC Class II Transactivator on the Growth and Metastasis of Breast Tumors. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada392812.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Thompson, James. Novel MHC Class II Breast Cancer Vaccine Using RNA Interference (RNAi) to Down-Regulate Invariant Chain (Ii). Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada425843.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!